StonvexLoading…
StonvexStonvexStonvexCore line items from INDV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.24B | $1.19B | $1.09B | $901.00M |
Operating Income | $262.00M | $38.00M | $-152.00M | $-81.00M |
Net Income | $210.00M | $7.00M | $-126.00M | $-44.00M |
EPS (Diluted) | $1.64 | $0.05 | $-0.92 | $-0.32 |
Total Assets | $1.20B | $1.32B | $1.76B | $1.77B |
Total Liabilities | $1.30B | $1.65B | $1.94B | $1.72B |
Cash & Equivalents | $195.00M | $319.00M | $316.00M | $774.00M |
Free Cash Flow OCF − CapEx | $-93.00M | $7.00M | $-308.00M | $-9.00M |
Shares Outstanding | 128.00M | 133.00M | 137.00M | 139.00M |